Institutional Biosafety Committee

The National Institutes of Health (NIH) has established mandatory guidelines for research involving recombinant DNA (rDNA). These guidelines specify practices for constructing and handling rDNA molecules and those organisms/viruses containing rDNA molecules. The role of Lewis & Clark College's Institutional Biosafety Committee (IBC) is to assure the safe and compliant handling of research involving recombinant DNA (rDNA) by Lewis & Clark investigators or by others at Lewis & Clark facilities.

IBC procedures are federally mandated. Regardless of the source of supporting funds, Principal Investigators (PIs) must have IBC approval to use recombinant DNA or other biohazardous materials prior to the initiation of the research. The PI is required to submit an application to the IBC. The IBC reviews for compliance with NIH Guidelines and approves those research projects it finds to be in conformity.

For more information, please contact the Sponsored Research Office at 503.768.7211.

Forms

Initial Recombinant DNA (rDNA) Research Classification Form (fillable pdf)

Recombinant DNA (rDNA) Research Questionnaire (fillable pdf)

Infectious Agent/Toxin Questionnaire (fillable pdf)

To review the Lewis & Clark College Policy on Recombinant DNA Research visit: http://www.lclark. edu/dept/hrpolicy/ researchdna.html

For more information on the Office of Biotechnolgoy Activities as related to Recombinant DNA and Gene Transfer Activities, please visit: http://www4.od.nih. gov/oba/Rdna.htm

Minutes of IBC meetings are available upon request. Please contact sponsres@lclark.edu for more information.